As of June 2026, the FDA's December 2024 Pharmacy Compounding Advisory Committee evaluation concluded that the criteria weighed against placing AOD-9604 (free base) or AOD-9604 acetate on the 503A Bulks List, and AOD-9604 is currently listed as Nominated but Withdrawn from FDA Category 2
Rao US, Fine RL, Scarborough GA
Suo H, Zhao X, Qian Y, Sun P, Zhu K, Li J, Sun B (2016) Lactobacillus fermentum suo attenuates HCl/ethanol induced gastric injury in mice through its antioxidant effects
Based on in vitro studies, NAC may interact with certain oral antibiotics
BPC-157 / TB-500 (Wolverine Stack) The Wolverine Stack combines BPC-157 and TB-500 into a single protocol unit at Perfect B